Mechanisms for the formation of protein-bound homocysteine in human plasma

Biochemical and Biophysical Research Communications

Volumn 277, Issue 3, 2000, Pages 668-674

  Togawa, Tadayasu ^a   Sengupta, Shantanu ^a   Chen, Hong ^a   Robinson, Killian ^a   Nonevski, Ilche ^b   Majors, Alana K ^a   Jacobsen, Donald W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b JOHN CARROLL UNIVERSITY   (United States)

Author keywords

Homocysteine; Homocysteine binding capacity; Hyperhomocysteinemia; Protein bound cysteine; Protein bound homocysteine

Indexed keywords

HOMOCYSTEINE;

AMINO ACID ANALYSIS; ARTICLE; BINDING AFFINITY; CARDIOVASCULAR DISEASE; HUMAN; HYPERHOMOCYSTEINEMIA; OXIDATION REDUCTION REACTION; PLASMA; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0034597712     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3723     Document Type: Article

References (39)

1. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease - Probable benefits of increasing folic acid intakes
2. Homocysteine and cardiovascular disease
3. Disorders of transsulfuration
4. Inherited disorders of folate transport and metabolism
5. Disorders of homocysteine metabolism
6. Clinical implications of hyperhomocysteinemia
7. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: Sex differences and correlation with cobalamin and folate levels in normal subjects
8. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status
9. Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease
10. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma
11. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Homocysteine and peripheral vascular disease
12. Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction
13. Homocysteine thiolactone: Metabolic origin and protein homocysteinylation in humans
14. Protein-bound homocyst(e) ine in normal subjects and in patients with homocystinuria
15. The effect of D-penicillamine on protein-bound homocyst(e) ine in homocystinurics
16. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with homocystinuria
17. Interrelations between plasma free and protein-bound homocysteine and cysteine in homocystinuria
18. Free and protein-bound homocysteine and cysteine in cystathionine b-synthase deficiency: Interrelations during short- and long-term changes in plasma concentrations
19. Plasma protein-bound homocyst(e) ine in patients requiring chronic haemodialysis
20. Altered plasma free and protein-bound sulfur amino acid levels in patients undergoing maintenance hemodialysis
21. Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure
22. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with hyperhomocysteinemia due to cobalamin deficiency
23. Protein-bound homocysteine: A possible risk factor for coronary artery disease
24. Transsulfuration in mammals. Microassays and tissue distribution of three enzymes of the pathway
25. Tissue sulfhydryl groups
26. Measurement of protein using bicinchoninic acid
27. Catalysis of thiol oxidation by cobalamins and cobinamides: Reaction products and kinetics
28. Relative nucleophilic reactivities of amino groups and mercaptide ions in addition reactions with a,b-unsaturated compounds
29. The acid strength of the -SH group in cysteine and related compounds
30. Dynamic relation between reduced, oxidized, and protein-bound homocysteine and other thiol components in plasma during methionine loading in healthy men
31. Redox status and protein binding of plasma aminothiols during the transient hyperhomocysteinemia that follows homocysteine administration
32. Homocysteine species as components of plasma redox thiol status
33. Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status - A possible element of the extracellular antioxidant defense system
34. Biological chemistry of thiols in the vasculature and in vascular-related disease
35. The use of cyst(e) ine in the removal of protein-bound homocysteine
36. Serum albumin
37. Radioenzymic determination of homocysteine in plasma and urine
38. Tissue plasminogen activator binding to the annexin II tail domain - Direct modulation by homocysteine